{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T07:04:45Z","timestamp":1784790285424,"version":"3.55.0"},"reference-count":9,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine and Research"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.resmer.2026.101300","type":"journal-article","created":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T15:17:09Z","timestamp":1783091829000},"page":"101300","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Effect of antibiotic therapy duration on risk of future exacerbations in patients with non-CF bronchiectasis"],"prefix":"10.1016","volume":"90","author":[{"given":"Rachel","family":"Solomons","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-9273-0301","authenticated-orcid":false,"given":"Charlotte","family":"Buchalter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmine","family":"Dunn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priya","family":"Ramachandran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camus","family":"Nimmo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.resmer.2026.101300_bib0001","first-page":"1","article-title":"British thoracic society guideline for bronchiectasis in adults","volume":"74","author":"Hill","year":"2019","journal-title":"Thorax"},{"key":"10.1016\/j.resmer.2026.101300_bib0002","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00629-2017","article-title":"European respiratory society guidelines for the management of adult bronchiectasis","volume":"50","author":"Polverino","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resmer.2026.101300_bib0003","doi-asserted-by":"crossref","first-page":"25","DOI":"10.21037\/atm-22-3437","article-title":"Bronchiectasis exacerbation: a narrative review of causes, risk factors, management and prevention","volume":"11","author":"Choi","year":"2023","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.resmer.2026.101300_bib0004","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01416-2021","article-title":"Less is more? Antibiotic treatment duration for exacerbations of bronchiectasis","volume":"58","author":"Chalmers","year":"2021","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resmer.2026.101300_bib0005","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1183\/13993003.01888-2015","article-title":"Research priorities in bronchiectasis: a consensus statement from the EMBARC Clinical Research Collaboration","volume":"48","author":"Aliberti","year":"2016","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resmer.2026.101300_bib0006","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.04388-2020","article-title":"Feasibility of shortening intravenous antibiotic therapy for bronchiectasis based on bacterial load: a proof-of-concept randomised controlled trial","volume":"58","author":"Bedi","year":"2021","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resmer.2026.101300_bib0007","unstructured":"NICE. Bronchiectasis (non-cystic fibrosis), acute exacerbation: antimicrobial prescribing (NG117). 2018; published online Dec 18. https:\/\/www.nice.org.uk\/guidance\/ng117. (accessed Sept 1, 2025)."},{"key":"10.1016\/j.resmer.2026.101300_bib0008","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S2213-2600(23)00093-0","article-title":"Bronchiectasis in Europe: data on disease characteristics from the European Bronchiectasis registry (EMBARC)","volume":"11","author":"Chalmers","year":"2023","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.resmer.2026.101300_bib0009","doi-asserted-by":"crossref","unstructured":"Hill A., Contact P. A. shorter duration of antibiotic treatment versus a longer duration of antibiotic treatment for patients with a flare up of their chronic lung condition requiring intravenous antibiotics. http:\/\/isrctn.com\/. https:\/\/doi.org\/10.1186\/ISRCTN14057228.","DOI":"10.1186\/ISRCTN14057228"}],"container-title":["Respiratory Medicine and Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590041226000541?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590041226000541?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T06:20:49Z","timestamp":1784787649000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590041226000541"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":9,"alternative-id":["S2590041226000541"],"URL":"https:\/\/doi.org\/10.1016\/j.resmer.2026.101300","relation":{},"ISSN":["2590-0412"],"issn-type":[{"value":"2590-0412","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of antibiotic therapy duration on risk of future exacerbations in patients with non-CF bronchiectasis","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine and Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.resmer.2026.101300","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 SPLF and Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101300"}}